David Goldstein

15PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples life courseCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 30, 2026
Multifactorial Contributors to Dose Limiting and Post-Treatment Neurologic Toxicity During Chemotherapy Treatment.

|Jun 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer.

|Apr 23, 2026
Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results.

|Jun 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

Michael Michael, Rachel Wong, Sanjeev Gill

|Apr 08, 2025
Navigating pain and appetite challenges in palliative care for pancreatic cancer: insights from a national, longitudinal consecutive cohort study.

Mariana S Sousa, Maja Villanueva Garcia, Megan Blanchard

|Mar 29, 2023
Irradiation-Induced Dysbiosis: The Compounding Effect of High-Fat Diet on Metabolic and Immune Functions in Mice.

Briana K Clifford, Nadia M L Amorim, Nadeem O Kaakoush

Pageof 3

Frequent Collaborators

6 joint publications

Megan C Best

6 joint publications

Mandy L Ballinger

6 joint publications

David Thomas

6 joint publications

Phyllis Butow